As demand for cell and gene therapies increases so does the demand for clinical trials. Industry leaders are focused on technology innovations, but struggle to find a holistic solution. While off-the-shelf digital solutions exist, they are typically focused on fragments of the overall process. As a result, they resort to the creation of bespoke solutions that create redundancies in the system. INTIENT Unify Cell & Gene connects stakeholders across the value chain, enabling manufacturers, supply chain partners and Healthcare Providers (HCPs) to work in a harmonized, standardized way.